ArticleResearch square2024

Combination of a MIP3α-antigen fusion therapeutic DNA vaccine with treatments of IFNα and 5-Aza-2'Deoxycytidine enhances activated effector CD8+ T cells expressing CD11c in the B16F10 melanoma model.

Kaitlyn Fessler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.